Evidence & regulatory context
- Mechanism
- No confident ChEMBL drug/compound match returned by name search. U-50488H is a selective kappa-opioid receptor agonist used as a preclinical tool compound; no clinical development identified.
- Target
- Not recorded
- Injury models
- TBI
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseTBIClosed-head / concussionCF-1 miceMale (mice)n = 4 untreated cats; mouse group sizes not statedIntravenousMice 1, 3 or 10 mg/kg for the grip test; 10 and 20 mg/kg fo…Within 3 to 5 min after concussive head injury
Model: Concussive head injury in mice (900 g/cm) and contusive spinal cord injury in cats (500 g/cm)
U-50488H produced a dose-related improvement in early neurological recovery in injured mice, significant at 3 and 10 mg/kg. It partially reversed the injury-induced fall in forebrain perfusion, significantly at 60 min after 20 mg/kg. In untreated cats spinal cord blood flow fell progressively from…
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.